Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
Ressources
Commentary | 2021
Clinical guidance, Harm reduction, Hesitancy of prescribers , Safer supply, About pharmacists
This paper examines patient characteristics and initial outcomes of patients served during a rapid protocol shift to telehealth that allowed buprenorphine initiation without an in-person encounter fol
Original research | 2021
Policy/Regulatory, About prescribers, Outcomes, Substitution/OAT, Digital health
Describes a 3-day induction protocol for injectable hydromorphone (HDM) and diacetylmorphine (DAM) used in 3 Canadian studies and examine rates of opioid-related overdose and somnolence during this in
Original research | 2019
Clinical guidance, Evidence base, Harm reduction, Safer supply, About prescribers, Outcomes, Substitution/OAT, Injecting drugs
Looked at characteristics of deceased drug users in treatment and not in treatment
Original research | 2021
Overdose, Mortality, Illegal drugs, Substitution/OAT
Our objective was to determine if US municipalities with high percentages of non-white residents have equitable access to the overdose antidote naloxone distributed by community-based organizations.
Original research | 2021
Overdose, Harm reduction, Equity
This study aimed to assess prevalence and reasons for using drugs alone among people accessing harm reduction services in BC.
Original research | 2020
Overdose, Harm reduction, Policy/Regulatory, Safer supply, About PWUD, Sex/Gender , Stigma
We compared injectable diacetylmorphine with oral methadone maintenance therapy in patients with opioid dependence that was refractory to treatment
Original research | 2009
Evidence base, Policy/Regulatory, Safer supply, About prescribers, Outcomes, Illegal drugs, Substitution/OAT
The study objectives are to identify the prevalence and correlates associated with smoking opioids.
Original research | 2021
Overdose, Policy/Regulatory, Decriminalization/legalization, Illegal drugs, Small/medium cities, Sex/Gender
To test if injectable hydromorphone hydrochloride is noninferior to injectable diacetylmorphine in reducing illicit heroin use for chronic injection opioid users after 6 months of intervention.
Original research | 2016
Evidence base, Policy/Regulatory, Safer supply, Advocacy, About prescribers, Outcomes, Illegal drugs, Substitution/OAT
The primary objective of this study was to examine the impacts associated with implementation of overdose preventions sites (OPSs) in Victoria, Canada during a declared provincial public health ove
Original research | 2020
Overdose, Harm reduction, Policy/Regulatory, Outcomes, Illegal drugs, Transitions in care/treatment, Stigma
We examined hospital staff's perspectives on the processes, challenges, and facilitators to buprenorphine initiation and warm handoff protocols in the ED
Original research | 2021
Overdose, Wrap-around services, About prescribers, Substitution/OAT, Transitions in care/treatment, Stigma, Hospitals
Recommend best injection practices to reduce infections, while keeping risk in mind
Report | 2015
Harm reduction, Policy/Regulatory, Safer supply, Injecting drugs, SCS/OPS
To test whether there are gender differences in treatment outcomes among patients receiving injectable opioids for the treatment of long-term opioid-dependence.
Original research | 2017
Evidence base, Safer supply, Outcomes, Crime, Illegal drugs, Sex/Gender
Illicit drug use while admitted to hospital is common amongst people who use drugs. Furthermore, non-medical prescription opioid use (NMPOU) is increasingly being used by this population.
Original research | 2021
Evidence base, Harm reduction, Safer supply, About prescribers, Illegal drugs, Hospitals
This study aims to model the distribution of different OAT medications within a naturalistic and relatively unrestricted treatment setting (Zurich, Switzerland) over time, and to identify patient char
Original research | 2018
Evidence base, Safer supply, Advocacy, About prescribers, Substitution/OAT, Social benefits
To describe the possible benefits of offering safe supply to people who use drugs during public health emergencies like COVID-19
Commentary | 2020
Safer supply, Stimulants
Recovery capital is a strengths-based concept representing the sum of an individual’s resources that support recovery.
Original research | 2021
Equity, Substitution/OAT, Sex/Gender
Webpage | 2021
Overdose, Policy/Regulatory, Safer supply, Advocacy, Outcomes, Illegal drugs, Injecting drugs
In this case it is presented and discussed that if a carry was possible during the pandemic, then the carry could continue post COVID-19 to address a gap in our approach to individualize care for p
Case study | 2021
Harm reduction, Policy/Regulatory, Safer supply, Outcomes, Injecting drugs, Diversion, Carries/take-home doses
In 2003, a randomised controlled trial comparing injected diacetylmorphine and oral methadone was carried out in Andalusia, Spain.
Original research | 2010
Evidence base, Harm reduction, Policy/Regulatory, Safer supply, About prescribers, Outcomes, Substitution/OAT
